1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Anti-Diabetic Drugs Market Size Growth Rate by Type: 2018 VS 2022 VS 2029 1.2.2 Biguanides 1.2.3 Sulfonylureas 1.2.4 Meglitinides 1.2.5 Thiazolidinediones 1.2.6 Dipeptidyl Peptidase IV Inhibitors 1.2.7 α-Glucosidase Inhibitors 1.3 Market by Application 1.3.1 Global Anti-Diabetic Drugs Market Growth by Application: 2018 VS 2022 VS 2029 1.3.2 Type I Diabetes 1.3.3 Type II Diabetes 1.3.4 Others 1.4 Study Objectives 1.5 Years Considered 1.6 Years Considered 2 Global Growth Trends 2.1 Global Anti-Diabetic Drugs Market Perspective (2018-2029) 2.2 Anti-Diabetic Drugs Growth Trends by Region 2.2.1 Global Anti-Diabetic Drugs Market Size by Region: 2018 VS 2022 VS 2029 2.2.2 Anti-Diabetic Drugs Historic Market Size by Region (2018-2023) 2.2.3 Anti-Diabetic Drugs Forecasted Market Size by Region (2024-2029) 2.3 Anti-Diabetic Drugs Market Dynamics 2.3.1 Anti-Diabetic Drugs Industry Trends 2.3.2 Anti-Diabetic Drugs Market Drivers 2.3.3 Anti-Diabetic Drugs Market Challenges 2.3.4 Anti-Diabetic Drugs Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Anti-Diabetic Drugs Players by Revenue 3.1.1 Global Top Anti-Diabetic Drugs Players by Revenue (2018-2023) 3.1.2 Global Anti-Diabetic Drugs Revenue Market Share by Players (2018-2023) 3.2 Global Anti-Diabetic Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Players Covered: Ranking by Anti-Diabetic Drugs Revenue 3.4 Global Anti-Diabetic Drugs Market Concentration Ratio 3.4.1 Global Anti-Diabetic Drugs Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Anti-Diabetic Drugs Revenue in 2022 3.5 Anti-Diabetic Drugs Key Players Head office and Area Served 3.6 Key Players Anti-Diabetic Drugs Product Solution and Service 3.7 Date of Enter into Anti-Diabetic Drugs Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Anti-Diabetic Drugs Breakdown Data by Type 4.1 Global Anti-Diabetic Drugs Historic Market Size by Type (2018-2023) 4.2 Global Anti-Diabetic Drugs Forecasted Market Size by Type (2024-2029) 5 Anti-Diabetic Drugs Breakdown Data by Application 5.1 Global Anti-Diabetic Drugs Historic Market Size by Application (2018-2023) 5.2 Global Anti-Diabetic Drugs Forecasted Market Size by Application (2024-2029) 6 North America 6.1 North America Anti-Diabetic Drugs Market Size (2018-2029) 6.2 North America Anti-Diabetic Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029 6.3 North America Anti-Diabetic Drugs Market Size by Country (2018-2023) 6.4 North America Anti-Diabetic Drugs Market Size by Country (2024-2029) 6.5 United States 6.6 Canada 7 Europe 7.1 Europe Anti-Diabetic Drugs Market Size (2018-2029) 7.2 Europe Anti-Diabetic Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029 7.3 Europe Anti-Diabetic Drugs Market Size by Country (2018-2023) 7.4 Europe Anti-Diabetic Drugs Market Size by Country (2024-2029) 7.5 Germany 7.6 France 7.7 U.K. 7.8 Italy 7.9 Russia 7.10 Nordic Countries 8 Asia-Pacific 8.1 Asia-Pacific Anti-Diabetic Drugs Market Size (2018-2029) 8.2 Asia-Pacific Anti-Diabetic Drugs Market Growth Rate by Region: 2018 VS 2022 VS 2029 8.3 Asia-Pacific Anti-Diabetic Drugs Market Size by Region (2018-2023) 8.4 Asia-Pacific Anti-Diabetic Drugs Market Size by Region (2024-2029) 8.5 China 8.6 Japan 8.7 South Korea 8.8 Southeast Asia 8.9 India 8.10 Australia 9 Latin America 9.1 Latin America Anti-Diabetic Drugs Market Size (2018-2029) 9.2 Latin America Anti-Diabetic Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029 9.3 Latin America Anti-Diabetic Drugs Market Size by Country (2018-2023) 9.4 Latin America Anti-Diabetic Drugs Market Size by Country (2024-2029) 9.5 Mexico 9.6 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Anti-Diabetic Drugs Market Size (2018-2029) 10.2 Middle East & Africa Anti-Diabetic Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029 10.3 Middle East & Africa Anti-Diabetic Drugs Market Size by Country (2018-2023) 10.4 Middle East & Africa Anti-Diabetic Drugs Market Size by Country (2024-2029) 10.5 Turkey 10.6 Saudi Arabia 10.7 UAE 11 Key Players Profiles 11.1 Astra Zeneca 11.1.1 Astra Zeneca Company Detail 11.1.2 Astra Zeneca Business Overview 11.1.3 Astra Zeneca Anti-Diabetic Drugs Introduction 11.1.4 Astra Zeneca Revenue in Anti-Diabetic Drugs Business (2018-2023) 11.1.5 Astra Zeneca Recent Development 11.2 Boehringer Ingelheim 11.2.1 Boehringer Ingelheim Company Detail 11.2.2 Boehringer Ingelheim Business Overview 11.2.3 Boehringer Ingelheim Anti-Diabetic Drugs Introduction 11.2.4 Boehringer Ingelheim Revenue in Anti-Diabetic Drugs Business (2018-2023) 11.2.5 Boehringer Ingelheim Recent Development 11.3 Eli Lilly 11.3.1 Eli Lilly Company Detail 11.3.2 Eli Lilly Business Overview 11.3.3 Eli Lilly Anti-Diabetic Drugs Introduction 11.3.4 Eli Lilly Revenue in Anti-Diabetic Drugs Business (2018-2023) 11.3.5 Eli Lilly Recent Development 11.4 Johnson & Johnson 11.4.1 Johnson & Johnson Company Detail 11.4.2 Johnson & Johnson Business Overview 11.4.3 Johnson & Johnson Anti-Diabetic Drugs Introduction 11.4.4 Johnson & Johnson Revenue in Anti-Diabetic Drugs Business (2018-2023) 11.4.5 Johnson & Johnson Recent Development 11.5 Merck 11.5.1 Merck Company Detail 11.5.2 Merck Business Overview 11.5.3 Merck Anti-Diabetic Drugs Introduction 11.5.4 Merck Revenue in Anti-Diabetic Drugs Business (2018-2023) 11.5.5 Merck Recent Development 11.6 Novartis 11.6.1 Novartis Company Detail 11.6.2 Novartis Business Overview 11.6.3 Novartis Anti-Diabetic Drugs Introduction 11.6.4 Novartis Revenue in Anti-Diabetic Drugs Business (2018-2023) 11.6.5 Novartis Recent Development 11.7 Novo Nordisk 11.7.1 Novo Nordisk Company Detail 11.7.2 Novo Nordisk Business Overview 11.7.3 Novo Nordisk Anti-Diabetic Drugs Introduction 11.7.4 Novo Nordisk Revenue in Anti-Diabetic Drugs Business (2018-2023) 11.7.5 Novo Nordisk Recent Development 11.8 Sanofi 11.8.1 Sanofi Company Detail 11.8.2 Sanofi Business Overview 11.8.3 Sanofi Anti-Diabetic Drugs Introduction 11.8.4 Sanofi Revenue in Anti-Diabetic Drugs Business (2018-2023) 11.8.5 Sanofi Recent Development 11.9 Teva Pharmaceutical Industries 11.9.1 Teva Pharmaceutical Industries Company Detail 11.9.2 Teva Pharmaceutical Industries Business Overview 11.9.3 Teva Pharmaceutical Industries Anti-Diabetic Drugs Introduction 11.9.4 Teva Pharmaceutical Industries Revenue in Anti-Diabetic Drugs Business (2018-2023) 11.9.5 Teva Pharmaceutical Industries Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Anti-Diabetic Drugs Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029 Table 2. Key Players of Biguanides Table 3. Key Players of Sulfonylureas Table 4. Key Players of Meglitinides Table 5. Key Players of Thiazolidinediones Table 6. Key Players of Dipeptidyl Peptidase IV Inhibitors Table 7. Key Players of α-Glucosidase Inhibitors Table 8. Global Anti-Diabetic Drugs Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029 Table 9. Global Anti-Diabetic Drugs Market Size by Region (US$ Million): 2018 VS 2022 VS 2029 Table 10. Global Anti-Diabetic Drugs Market Size by Region (2018-2023) & (US$ Million) Table 11. Global Anti-Diabetic Drugs Market Share by Region (2018-2023) Table 12. Global Anti-Diabetic Drugs Forecasted Market Size by Region (2024-2029) & (US$ Million) Table 13. Global Anti-Diabetic Drugs Market Share by Region (2024-2029) Table 14. Anti-Diabetic Drugs Market Trends Table 15. Anti-Diabetic Drugs Market Drivers Table 16. Anti-Diabetic Drugs Market Challenges Table 17. Anti-Diabetic Drugs Market Restraints Table 18. Global Anti-Diabetic Drugs Revenue by Players (2018-2023) & (US$ Million) Table 19. Global Anti-Diabetic Drugs Market Share by Players (2018-2023) Table 20. Global Top Anti-Diabetic Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-Diabetic Drugs as of 2022) Table 21. Ranking of Global Top Anti-Diabetic Drugs Companies by Revenue (US$ Million) in 2022 Table 22. Global 5 Largest Players Market Share by Anti-Diabetic Drugs Revenue (CR5 and HHI) & (2018-2023) Table 23. Key Players Headquarters and Area Served Table 24. Key Players Anti-Diabetic Drugs Product Solution and Service Table 25. Date of Enter into Anti-Diabetic Drugs Market Table 26. Mergers & Acquisitions, Expansion Plans Table 27. Global Anti-Diabetic Drugs Market Size by Type (2018-2023) & (US$ Million) Table 28. Global Anti-Diabetic Drugs Revenue Market Share by Type (2018-2023) Table 29. Global Anti-Diabetic Drugs Forecasted Market Size by Type (2024-2029) & (US$ Million) Table 30. Global Anti-Diabetic Drugs Revenue Market Share by Type (2024-2029) Table 31. Global Anti-Diabetic Drugs Market Size by Application (2018-2023) & (US$ Million) Table 32. Global Anti-Diabetic Drugs Revenue Market Share by Application (2018-2023) Table 33. Global Anti-Diabetic Drugs Forecasted Market Size by Application (2024-2029) & (US$ Million) Table 34. Global Anti-Diabetic Drugs Revenue Market Share by Application (2024-2029) Table 35. North America Anti-Diabetic Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029 Table 36. North America Anti-Diabetic Drugs Market Size by Country (2018-2023) & (US$ Million) Table 37. North America Anti-Diabetic Drugs Market Size by Country (2024-2029) & (US$ Million) Table 38. Europe Anti-Diabetic Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029 Table 39. Europe Anti-Diabetic Drugs Market Size by Country (2018-2023) & (US$ Million) Table 40. Europe Anti-Diabetic Drugs Market Size by Country (2024-2029) & (US$ Million) Table 41. Asia-Pacific Anti-Diabetic Drugs Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029 Table 42. Asia-Pacific Anti-Diabetic Drugs Market Size by Region (2018-2023) & (US$ Million) Table 43. Asia-Pacific Anti-Diabetic Drugs Market Size by Region (2024-2029) & (US$ Million) Table 44. Latin America Anti-Diabetic Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029 Table 45. Latin America Anti-Diabetic Drugs Market Size by Country (2018-2023) & (US$ Million) Table 46. Latin America Anti-Diabetic Drugs Market Size by Country (2024-2029) & (US$ Million) Table 47. Middle East & Africa Anti-Diabetic Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029 Table 48. Middle East & Africa Anti-Diabetic Drugs Market Size by Country (2018-2023) & (US$ Million) Table 49. Middle East & Africa Anti-Diabetic Drugs Market Size by Country (2024-2029) & (US$ Million) Table 50. Astra Zeneca Company Detail Table 51. Astra Zeneca Business Overview Table 52. Astra Zeneca Anti-Diabetic Drugs Product Table 53. Astra Zeneca Revenue in Anti-Diabetic Drugs Business (2018-2023) & (US$ Million) Table 54. Astra Zeneca Recent Development Table 55. Boehringer Ingelheim Company Detail Table 56. Boehringer Ingelheim Business Overview Table 57. Boehringer Ingelheim Anti-Diabetic Drugs Product Table 58. Boehringer Ingelheim Revenue in Anti-Diabetic Drugs Business (2018-2023) & (US$ Million) Table 59. Boehringer Ingelheim Recent Development Table 60. Eli Lilly Company Detail Table 61. Eli Lilly Business Overview Table 62. Eli Lilly Anti-Diabetic Drugs Product Table 63. Eli Lilly Revenue in Anti-Diabetic Drugs Business (2018-2023) & (US$ Million) Table 64. Eli Lilly Recent Development Table 65. Johnson & Johnson Company Detail Table 66. Johnson & Johnson Business Overview Table 67. Johnson & Johnson Anti-Diabetic Drugs Product Table 68. Johnson & Johnson Revenue in Anti-Diabetic Drugs Business (2018-2023) & (US$ Million) Table 69. Johnson & Johnson Recent Development Table 70. Merck Company Detail Table 71. Merck Business Overview Table 72. Merck Anti-Diabetic Drugs Product Table 73. Merck Revenue in Anti-Diabetic Drugs Business (2018-2023) & (US$ Million) Table 74. Merck Recent Development Table 75. Novartis Company Detail Table 76. Novartis Business Overview Table 77. Novartis Anti-Diabetic Drugs Product Table 78. Novartis Revenue in Anti-Diabetic Drugs Business (2018-2023) & (US$ Million) Table 79. Novartis Recent Development Table 80. Novo Nordisk Company Detail Table 81. Novo Nordisk Business Overview Table 82. Novo Nordisk Anti-Diabetic Drugs Product Table 83. Novo Nordisk Revenue in Anti-Diabetic Drugs Business (2018-2023) & (US$ Million) Table 84. Novo Nordisk Recent Development Table 85. Sanofi Company Detail Table 86. Sanofi Business Overview Table 87. Sanofi Anti-Diabetic Drugs Product Table 88. Sanofi Revenue in Anti-Diabetic Drugs Business (2018-2023) & (US$ Million) Table 89. Sanofi Recent Development Table 90. Teva Pharmaceutical Industries Company Detail Table 91. Teva Pharmaceutical Industries Business Overview Table 92. Teva Pharmaceutical Industries Anti-Diabetic Drugs Product Table 93. Teva Pharmaceutical Industries Revenue in Anti-Diabetic Drugs Business (2018-2023) & (US$ Million) Table 94. Teva Pharmaceutical Industries Recent Development Table 95. Research Programs/Design for This Report Table 96. Key Data Information from Secondary Sources Table 97. Key Data Information from Primary Sources List of Figures Figure 1. Global Anti-Diabetic Drugs Market Size Comparison by Type (2023-2029) & (US$ Million) Figure 2. Global Anti-Diabetic Drugs Market Share by Type: 2022 VS 2029 Figure 3. Biguanides Features Figure 4. Sulfonylureas Features Figure 5. Meglitinides Features Figure 6. Thiazolidinediones Features Figure 7. Dipeptidyl Peptidase IV Inhibitors Features Figure 8. α-Glucosidase Inhibitors Features Figure 9. Global Anti-Diabetic Drugs Market Size Comparison by Application (2023-2029) & (US$ Million) Figure 10. Global Anti-Diabetic Drugs Market Share by Application: 2022 VS 2029 Figure 11. Type I Diabetes Case Studies Figure 12. Type II Diabetes Case Studies Figure 13. Others Case Studies Figure 14. Anti-Diabetic Drugs Report Years Considered Figure 15. Global Anti-Diabetic Drugs Market Size (US$ Million), Year-over-Year: 2018-2029 Figure 16. Global Anti-Diabetic Drugs Market Size, (US$ Million), 2018 VS 2022 VS 2029 Figure 17. Global Anti-Diabetic Drugs Market Share by Region: 2022 VS 2029 Figure 18. Global Anti-Diabetic Drugs Market Share by Players in 2022 Figure 19. Global Top Anti-Diabetic Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-Diabetic Drugs as of 2022) Figure 20. The Top 10 and 5 Players Market Share by Anti-Diabetic Drugs Revenue in 2022 Figure 21. North America Anti-Diabetic Drugs Market Size YoY Growth (2018-2029) & (US$ Million) Figure 22. North America Anti-Diabetic Drugs Market Share by Country (2018-2029) Figure 23. United States Anti-Diabetic Drugs Market Size YoY Growth (2018-2029) & (US$ Million) Figure 24. Canada Anti-Diabetic Drugs Market Size YoY Growth (2018-2029) & (US$ Million) Figure 25. Europe Anti-Diabetic Drugs Market Size YoY Growth (2018-2029) & (US$ Million) Figure 26. Europe Anti-Diabetic Drugs Market Share by Country (2018-2029) Figure 27. Germany Anti-Diabetic Drugs Market Size YoY Growth (2018-2029) & (US$ Million) Figure 28. France Anti-Diabetic Drugs Market Size YoY Growth (2018-2029) & (US$ Million) Figure 29. U.K. Anti-Diabetic Drugs Market Size YoY Growth (2018-2029) & (US$ Million) Figure 30. Italy Anti-Diabetic Drugs Market Size YoY Growth (2018-2029) & (US$ Million) Figure 31. Russia Anti-Diabetic Drugs Market Size YoY Growth (2018-2029) & (US$ Million) Figure 32. Nordic Countries Anti-Diabetic Drugs Market Size YoY Growth (2018-2029) & (US$ Million) Figure 33. Asia-Pacific Anti-Diabetic Drugs Market Size YoY Growth (2018-2029) & (US$ Million) Figure 34. Asia-Pacific Anti-Diabetic Drugs Market Share by Region (2018-2029) Figure 35. China Anti-Diabetic Drugs Market Size YoY Growth (2018-2029) & (US$ Million) Figure 36. Japan Anti-Diabetic Drugs Market Size YoY Growth (2018-2029) & (US$ Million) Figure 37. South Korea Anti-Diabetic Drugs Market Size YoY Growth (2018-2029) & (US$ Million) Figure 38. Southeast Asia Anti-Diabetic Drugs Market Size YoY Growth (2018-2029) & (US$ Million) Figure 39. India Anti-Diabetic Drugs Market Size YoY Growth (2018-2029) & (US$ Million) Figure 40. Australia Anti-Diabetic Drugs Market Size YoY Growth (2018-2029) & (US$ Million) Figure 41. Latin America Anti-Diabetic Drugs Market Size YoY Growth (2018-2029) & (US$ Million) Figure 42. Latin America Anti-Diabetic Drugs Market Share by Country (2018-2029) Figure 43. Mexico Anti-Diabetic Drugs Market Size YoY Growth (2018-2029) & (US$ Million) Figure 44. Brazil Anti-Diabetic Drugs Market Size YoY Growth (2018-2029) & (US$ Million) Figure 45. Middle East & Africa Anti-Diabetic Drugs Market Size YoY Growth (2018-2029) & (US$ Million) Figure 46. Middle East & Africa Anti-Diabetic Drugs Market Share by Country (2018-2029) Figure 47. Turkey Anti-Diabetic Drugs Market Size YoY Growth (2018-2029) & (US$ Million) Figure 48. Saudi Arabia Anti-Diabetic Drugs Market Size YoY Growth (2018-2029) & (US$ Million) Figure 49. Astra Zeneca Revenue Growth Rate in Anti-Diabetic Drugs Business (2018-2023) Figure 50. Boehringer Ingelheim Revenue Growth Rate in Anti-Diabetic Drugs Business (2018-2023) Figure 51. Eli Lilly Revenue Growth Rate in Anti-Diabetic Drugs Business (2018-2023) Figure 52. Johnson & Johnson Revenue Growth Rate in Anti-Diabetic Drugs Business (2018-2023) Figure 53. Merck Revenue Growth Rate in Anti-Diabetic Drugs Business (2018-2023) Figure 54. Novartis Revenue Growth Rate in Anti-Diabetic Drugs Business (2018-2023) Figure 55. Novo Nordisk Revenue Growth Rate in Anti-Diabetic Drugs Business (2018-2023) Figure 56. Sanofi Revenue Growth Rate in Anti-Diabetic Drugs Business (2018-2023) Figure 57. Teva Pharmaceutical Industries Revenue Growth Rate in Anti-Diabetic Drugs Business (2018-2023) Figure 58. Bottom-up and Top-down Approaches for This Report Figure 59. Data Triangulation Figure 60. Key Executives Interviewed

Astra Zeneca Boehringer Ingelheim Eli Lilly Johnson & Johnson Merck Novartis Novo Nordisk Sanofi Teva Pharmaceutical Industries